We provide you with 20 years of free, institutional-grade data for BMY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BMY. Explore the full financial landscape of BMY stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-07-31 | 14272 | BMY | 10-Q | Url |
2025-04-24 | 14272 | BMY | 10-Q | Url |
2025-02-12 | 14272 | BMY | 10-K | Url |
2024-10-31 | 14272 | BMY | 10-Q | Url |
2024-07-26 | 14272 | BMY | 10-Q | Url |
2024-04-25 | 14272 | BMY | 10-Q | Url |
2024-02-13 | 14272 | BMY | 10-K | Url |
2023-10-26 | 14272 | BMY | 10-Q | Url |
2023-07-27 | 14272 | BMY | 10-Q | Url |
2023-04-27 | 14272 | BMY | 10-Q | Url |
2023-02-14 | 14272 | BMY | 10-K | Url |
2022-10-26 | 14272 | BMY | 10-Q | Url |
2022-07-27 | 14272 | BMY | 10-Q | Url |
2022-04-29 | 14272 | BMY | 10-Q | Url |
2022-02-09 | 14272 | BMY | 10-K | Url |
2021-10-27 | 14272 | BMY | 10-Q | Url |
2021-07-28 | 14272 | BMY | 10-Q | Url |
2021-04-29 | 14272 | BMY | 10-Q | Url |
2021-02-10 | 14272 | BMY | 10-K | Url |
2020-11-05 | 14272 | BMY | 10-Q | Url |
2020-08-06 | 14272 | BMY | 10-Q | Url |
2020-05-07 | 14272 | BMY | 10-Q | Url |
2020-02-24 | 14272 | BMY | 10-K | Url |
2019-10-31 | 14272 | BMY | 10-Q | Url |
2019-07-25 | 14272 | BMY | 10-Q | Url |
2019-04-25 | 14272 | BMY | 10-Q | Url |
2019-02-25 | 14272 | BMY | 10-K | Url |
2018-10-25 | 14272 | BMY | 10-Q | Url |
2018-07-26 | 14272 | BMY | 10-Q | Url |
2018-04-26 | 14272 | BMY | 10-Q | Url |
2018-02-13 | 14272 | BMY | 10-K | Url |
2017-10-26 | 14272 | BMY | 10-Q | Url |
2017-07-27 | 14272 | BMY | 10-Q | Url |
2017-04-27 | 14272 | BMY | 10-Q | Url |
2017-02-21 | 14272 | BMY | 10-K | Url |
2016-10-27 | 14272 | BMY | 10-Q | Url |
2016-07-28 | 14272 | BMY | 10-Q | Url |
2016-04-28 | 14272 | BMY | 10-Q | Url |
2016-02-12 | 14272 | BMY | 10-K | Url |
2015-10-27 | 14272 | BMY | 10-Q | Url |
2015-07-23 | 14272 | BMY | 10-Q | Url |
2015-04-28 | 14272 | BMY | 10-Q | Url |
2015-02-13 | 14272 | BMY | 10-K | Url |
2014-10-24 | 14272 | BMY | 10-Q | Url |
2014-07-24 | 14272 | BMY | 10-Q | Url |
2014-04-29 | 14272 | BMY | 10-Q | Url |
2014-02-14 | 14272 | BMY | 10-K | Url |
2013-10-23 | 14272 | BMY | 10-Q | Url |
2013-07-25 | 14272 | BMY | 10-Q | Url |
2013-04-25 | 14272 | BMY | 10-Q | Url |
2013-02-15 | 14272 | BMY | 10-K | Url |
2012-10-24 | 14272 | BMY | 10-Q | Url |
2012-07-25 | 14272 | BMY | 10-Q | Url |
2012-04-26 | 14272 | BMY | 10-Q | Url |
2012-02-17 | 14272 | BMY | 10-K | Url |
2011-10-27 | 14272 | BMY | 10-Q | Url |
2011-07-28 | 14272 | BMY | 10-Q | Url |
2011-04-28 | 14272 | BMY | 10-Q | Url |
2011-02-18 | 14272 | BMY | 10-K | Url |
2010-10-26 | 14272 | BMY | 10-Q | Url |
2010-07-22 | 14272 | BMY | 10-Q | Url |
2010-04-29 | 14272 | BMY | 10-Q | Url |
Bristol-Myers Squibb Company(NYSE:BMY)

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the tr...
Website: http://www.bms.com
Founded: 1887
Full Time Employees: 30,000
Sector: Healthcare
Industry: Drug Manufacturers-General
The information provided in this report about BMY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.